David Drasin joined UCLA TDG in August 2017 as part of the New Ventures team. His primary focus as New Ventures Principal is to facilitate the advancement of projects from early data to market, through the UCLA Innovation Fund. In addition, through the Startup in a Box program, David supports UCLA entrepreneurs as they establish and grow their ventures. Prior to joining the New Ventures team, David was a consultant at BluePrint Research Group, specializing in biopharma commercial strategy across a broad range of therapeutic areas. David received his B.S. from UCLA in Microbiology, Immunology and Molecular Genetics and his Ph.D. form the University of Colorado Anschutz Medical Campus in Molecular Biology, in addition to a brief postdoctoral training period at UCSF.